Nagoya City University
Nagoya, Aichi, Japan
Public university in Nagoya
〒467-8601 Aichi, Nagoya, Mizuho Ward, Mizuhocho, Kawasumi−１
About Nagoya City University
Nagoya City University, abbreviated to Meishidai, is a public university in Japan. The main campus is located in Mizuho-ku, Nagoya City. Other three campuses are also located in the city. Nagoya City University has been ranked the highest among public universities which is also one of leading universities in Japan.
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Nagoya City University
3
Kyoto University
1
National Cancer Institute (NCI)
1
Stanford University
1
Clinical Trials at Nagoya City University
During the past decade, Nagoya City University conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 0 clinical trials were completed, i.e. on
average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Telephone Cognitive-Behavioral Therapy (CBT) for Subthreshold Depression and Presenteeism in Workplace
2009-04-01
2011-09-01
Completed
118
Evaluation of the Usefulness of a Treat and Extend Regimen Using Ranibizumab for Neovascular AMD.
2014-01-01
2019-03-01
Completed
78
Evaluation of the Usefulness of a PRN Regimen Using Ranibizumab for Macular Edema Due to Branch Retinal Vein Occlusion
2014-01-01
2019-03-01
Completed
27
Acceptance and Commitment Therapy With Vestibular Rehabilitation for Chronic Dizziness
2017-04-25
2021-10-31
Unknown status
60
Treatment Outcomes in Chronic Hepatitis B Patients on Sequential Therapy With Tenofovir Alafenamide (TAF)
2018-05-01
2022-11-30
Active, not recruiting
266
Clinical Trials Sponsors and Collaborators
In terms of collaborators to trials, out of the total clinical trials conducted in "Nagoya City University"
#1 collaborator was "Novartis" with 2 trials as a collaborator, "Chiba University, Japan" with 1 trials as a collaborator, "Gilead Sciences" with 1 trials as a collaborator, "HOSEI University, Japan" with 1 trials as a collaborator and "Instituto Mexicano de Seguro Social, Mexico" with 1 trials as a collaborator. Other collaborators include 8 different institutions and companies that were
collaborators in the rest 18 trials.
Clinical Trials Conditions at Nagoya City University
According to Clinical.Site data, the most researched conditions in "Nagoya City University" are
"Branch Retinal Vein Occlusion" (1 trials), "Chronic Dizziness" (1 trials), "Depression" (1 trials), "Gastric Cancer" (1 trials) and "Hepatitis B, Chronic" (1 trials). Many other conditions were trialed in "Nagoya City University" in a lesser frequency.
Clinical Trials Intervention Types at Nagoya City University
Most popular intervention types in "Nagoya City University" are "Drug" (3 trials), "Behavioral" (2 trials) and "Other" (1 trials). Other intervention types were less common.
The name of intervention was led by "ACT with VR" (1 trials), "CBT" (1 trials), "EAP" (1 trials), "Intraviteal Ranibizumab 0.5mg" (1 trials) and "Ranibizumab" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Nagoya City University
The vast majority of trials in "Nagoya City University" are
6 trials for "All" genders.
Clinical Trials Status at Nagoya City University
Currently, there are NaN active trials in "Nagoya City University".
undefined are not yet recruiting,
undefined are recruiting,
1 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 3 completed trials in Nagoya City University,
undefined suspended trials,
and 1 terminated clinical trials to date.
Out of the total trials that were conducted in Nagoya City University, 0 "Phase 1"
clinical trials were conducted, 1 "Phase 2" clinical
trials and 1 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 3 trials, and there were
also 1 trials that are defined as “Not Applicable".